Literature DB >> 15633045

Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease.

S Kurotobi1, N Kawakami, K Shimizu, H Aoki, S Nasuno, K Takahashi, S Kogaki, K Ozono.   

Abstract

Although an increased level of serum brain natriuretic peptide (BNP) has been reported in children in the acute phase of Kawasaki disease (KD), no precise relation was documented between the serum BNP level and left ventricular (LV) systolic function. We hypothesized that the increased BNP levels may be explained by diastolic abnormalities in those with KD. We prospectively studied 25 patients in the acute phase of KD. Patients with abnormal systolic function were excluded. Pediatric cardiologists making the assessment of LV diastolic function were blinded to the BNP levels. Doppler interrogation was applied to measure LV inflow velocities, which were transformed to z scores using control measurements obtained from 83 healthy subjects. In the patients, the BNP levels ranged from 2.0 to 450.0 pg/ml, with a mean of 54.0 +/- 102.8 pg/ml. Six patients with abnormal velocities (> 2 SD in z score) showed significantly higher levels of BNP (152 +/- 173 pg/ml) than those in the remaining patients (p < 0.01). The BNP levels correlated positively with diastolic atrial velocity in z score (r = 0.51, p < 0.05), and negatively with diastolic early velocity to atrial velocity ratio in z score (r = -0.75, p < 0.01). This study suggests that LV diastolic dysfunction may occur in some children in the acute phase of KD, causing an increased level of BNP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15633045     DOI: 10.1007/s00246-004-0812-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

1.  Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease.

Authors:  H Suzuki; S Uemura; S Tone; T Iizuka; M Koike; K Hirayama; J Maeda
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

Review 2.  Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.

Authors:  A Kjaer; B Hesse
Journal:  Clin Physiol       Date:  2001-11

3.  [Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki disease].

Authors:  T Matsubara
Journal:  Arerugi       Date:  1991-02

4.  Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease.

Authors:  Takashi Kawamura; Masakuni Wago
Journal:  Cardiol Young       Date:  2002-03       Impact factor: 1.093

5.  Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

Authors:  K Yamamoto; J C Burnett; M Jougasaki; R A Nishimura; K R Bailey; Y Saito; K Nakao; M M Redfield
Journal:  Hypertension       Date:  1996-12       Impact factor: 10.190

6.  Left ventricular diastolic function in children measured by Doppler echocardiography: normal values and relation with growth.

Authors:  F A Bu'Lock; M G Mott; R P Martin
Journal:  Br Heart J       Date:  1995-04

7.  Brain natriuretic peptide as a cardiac hormone in essential hypertension.

Authors:  M Kohno; T Horio; K Yokokawa; K Murakawa; K Yasunari; K Akioka; A Tahara; I Toda; K Takeuchi; N Kurihara
Journal:  Am J Med       Date:  1992-01       Impact factor: 4.965

8.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

9.  Role of age on transmitral flow velocity patterns in assessing left ventricular diastolic function in normal infants and children.

Authors:  K Harada; T Suzuki; M Tamura; T Ito; Y Takahashi; K Shimada; G Takada
Journal:  Am J Cardiol       Date:  1995-09-01       Impact factor: 2.778

10.  Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth.

Authors:  M Yoshibayashi; T Kamiya; Y Saito; K Nakao; K Nishioka; S Temma; H Itoh; G Shirakami; H Matsuo
Journal:  Eur J Endocrinol       Date:  1995-08       Impact factor: 6.664

View more
  24 in total

Review 1.  Plasma B-type natriuretic peptides in children with cardiovascular diseases.

Authors:  Bibhuti B Das
Journal:  Pediatr Cardiol       Date:  2010-10-07       Impact factor: 1.655

2.  Myocardial Layers Specific Strain Analysis for the Acute Phase of Infant Kawasaki Disease.

Authors:  Lucy Youngmin Eun; Ji Hong Kim; Jo Won Jung; Jae Young Choi
Journal:  Pediatr Cardiol       Date:  2016-07-09       Impact factor: 1.655

3.  Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease.

Authors:  Daniel Phadke; Sonali S Patel; Samuel R Dominguez; Heather Heizer; Marsha S Anderson; Mary P Glode; Pei-Ni Jone
Journal:  Pediatr Cardiol       Date:  2015-05-21       Impact factor: 1.655

Review 4.  Assessing cardiovascular risk in children with chronic kidney disease. B-type natriuretic peptide: a potential new marker.

Authors:  Gema Ariceta; Ellen R Brooks; Craig B Langman
Journal:  Pediatr Nephrol       Date:  2005-08-05       Impact factor: 3.714

5.  Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.

Authors:  Kazunari Kaneko; Ken Yoshimura; Atsushi Ohashi; Takahisa Kimata; Tomohiko Shimo; Shoji Tsuji
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

6.  Impairment of Left Ventricular Longitudinal Contraction is Associated with Serum Brain Natriuretic Peptide Concentration in Patients with Acute-Phase Kawasaki Disease.

Authors:  Ikuo Hashimoto; Kazuhiro Watanabe; Mako Okabe; Hisashi Kaneda
Journal:  Pediatr Cardiol       Date:  2015-01-28       Impact factor: 1.655

7.  Predictive risk factors for coronary artery abnormalities in Kawasaki disease.

Authors:  Taeyeun Kim; Wooksun Choi; Chan-Wook Woo; Byungmin Choi; Junghwa Lee; Kwangchul Lee; Changsung Son; Joowon Lee
Journal:  Eur J Pediatr       Date:  2006-10-11       Impact factor: 3.183

8.  N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.

Authors:  So Youn Kim; Mi Young Han; Sung-Ho Cha; Yang Bin Jeon
Journal:  Pediatr Cardiol       Date:  2013-06-07       Impact factor: 1.655

Review 9.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

10.  B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.

Authors:  Satoru Iwashima; Takamichi Ishikawa
Journal:  World J Pediatr       Date:  2013-01-18       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.